Robbins Geller Obtains Final Approval of $108 Million Settlement in Orbital Securities Class Action
On June 7, 2019, the Honorable T.S. Ellis III granted final approval of a $108 million settlement in Knurr v. Orbital ATK, Inc. Believed to be the fourth-largest securities class action settlement in the history of the Eastern District of Virginia, the settlement provides a recovery for investors that is more than ten times larger than the reported median recovery of estimated damages for all securities class action settlements in 2018.
The case arises from Orbital ATK’s announcement on August 10, 2016 that it would be restating its previously issued financial statements to record an approximately $375 million loss on its largest contract. Plaintiffs alleged that defendants made false and misleading statements, both during the class period and in connection with the merger that formed Orbital ATK, that misrepresented the performance of the Lake City contract and concealed the massive loss. Plaintiffs maintained that defendants had no reasonable basis to report that the Lake City contract was profitable during the class period because the contract was bid far below historical manufacturing costs and the company was not achieving the savings necessary to make the contract profitable.
Robbins Geller succeeded in overcoming two successive motions to dismiss the case, and during discovery were required to file ten motions to compel, all of which were either negotiated to a resolution or granted in large part, which resulted in the production of critical evidence in support of plaintiffs’ claims.
In approving the settlement, the court lauded Robbins Geller’s efforts in achieving the $108 million settlement with “skill, perseverance, and diligent advocacy.”
Knurr v. Orbital ATK, Inc., No. 1:16-cv-01031 (E.D. Va.).
Read More Firm News
- January 20, 2022
- “Bailout” – In Closing Arguments of Tesla Trial, Partner Randy Baron Challenges Elon Musk’s Role in the Acquisition of SolarCityJanuary 18, 2022
- Law360: Despite Throwing Up “Every Hurdle in the Book,” Maker of EpiPen Faces “Day of Reckoning” in Antitrust SuitDecember 16, 2021
- December 8, 2021
- December 7, 2021